Novartis, headquartered in East Hanover, New Jersey, United States, is a global pharmaceutical company. It was founded in 1996 through the merger of Ciba-Geigy and Sandoz, two Swiss pharmaceutical giants with long histories dating back to the late 19th century. Novartis focuses on developing innovative pharmaceutical products, eye care products, generic medicines, and over-the-counter drugs.

They aim to provide solutions to complex healthcare challenges and improve people's lives. The company's main therapeutic areas include cardiovascular, immunology, neuroscience, oncology, ophthalmology, and respiratory. Operating on a global scale, Novartis has numerous noteworthy subsidiaries, joint ventures, and partnerships.

Some of its subsidiaries include Alcon, a leading eye care company, and Sandoz, a major player in the generic pharmaceutical market. Novartis also has joint ventures with companies like GSK Consumer Healthcare and operates partnerships with academic institutions, research organizations, and non-profit organizations to foster innovation and research in the healthcare industry. In terms of market position, Novartis is one of the largest pharmaceutical companies globally.

It consistently ranks among the top players in the industry. In 2020, the company reported net sales of approximately $48 billion. Novartis has achieved several significant milestones and made notable contributions to the healthcare industry.

The company pioneered the development of breakthrough drugs like Gleevec, which revolutionized the treatment of chronic myeloid leukemia. They have also made advancements in the field of gene therapy and have a robust pipeline of innovative drugs. Currently, Novartis continues to expand its portfolio, focusing on high-growth areas and investing in research and development.

The company constantly seeks opportunities to collaborate with partners to bring cutting-edge treatments to patients worldwide. Novartis remains committed to addressing global health challenges and playing a prominent role in shaping the future of medicine